The Acurate neo2 TAVR valve has been used to treat severe aortic stenosis in other parts of the world for years. In the United States, however, the device has still not been approved for commercial use.  

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

The CEO of the country’s largest for-profit, publicly traded health system is bullish on healthcare AI. 

Discussions of AI governance may cause many an eye to glass over, but the discipline is as crucial to the ascent of AI in healthcare as big training datasets drawn from diverse patient populations.

Physical therapy practices in greater Philadelphia are of particular interest to private equity firms, with 271 locations owned by six companies. The report comes from the Private Equity Stakeholder Project (PESP). 

Treating AMI patients with colchicine is not associated with better cardiovascular outcomes, according to new data presented at TCT. The drug did help with inflammation, but that was the only benefit researchers could identify.

ACR is adding new entries covering scenarios such as brain tumors, inflammatory ear disease, and lung cancer staging after therapy. 

The former Medicaid Director of Texas, Gary Jessee, tells HealthExec that state healthcare programs are raising the bar for care access and quality, even for patients covered by commercial plans.